Posted on 9월 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on 9월 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Posted on 8월 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky
Posted on 7월 17, 20247/17/24
In-Depth with an Industry Leader: Global Launch Ambitions and Paradigm Shifts
Posted on 4월 16, 20244/16/24
Navigating Pharmaceutical Success: Harnessing Data Analytics and Predictive Modeling
Posted on 3월 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
Posted on 1월 3, 20241/3/24
Transforming Pharmaceutical Commercialization: Eight Key Insights for Success
Posted on 7월 13, 20237/13/23
Overcoming the Commercialization Challenges of Personalized Cancer Immunotherapies
Posted on 6월 16, 20236/16/23